文献速递产科母胎医学

全基因组测序与染色体微阵列分析在产前诊断中的比较

Whole genome sequencing vs chromosomal microarray analysis in prenatal diagnosis.
PubMed 文献 · Am J Obstet Gynecol · 2023-03-11

这项前瞻性研究纳入185例超声发现结构异常的未选择单胎胎儿,平行进行全基因组测序与染色体微阵列分析。全基因组测序遗传诊断28例(15.1%),覆盖染色体微阵列分析诊断的全部20例(10.8%),并额外检出8例,额外检出率5.9%(11/185)。作者认为全基因组测序有潜力成为胎儿结构异常的新型产前诊断检测。

要点

  • 全基因组测序遗传诊断28例(15.1%),染色体微阵列分析诊断20例(10.8%)。
  • 全基因组测序额外检出率5.9%(11/185),包括1例COL4A2外显子缺失和7例单核苷酸变异或插入缺失。
  • 全基因组测序检出3例偶然发现, turnaround time(周转时间)为3–4周。

核心结论

  • 与染色体微阵列分析相比,全基因组测序额外检出率增加5.9%(11/185)。
  • 全基因组测序不仅检出非整倍体和拷贝数变异,还检出单核苷酸变异、插入缺失、三核苷酸重复扩增和外显子拷贝数变异,准确度高,周转时间可接受(3–4周)。
  • 作者认为全基因组测序有潜力成为胎儿结构异常的新型产前诊断检测。

研究设计与样本

  • 前瞻性研究,纳入185例超声发现结构异常的未选择单胎胎儿。
  • 每例样本平行进行全基因组测序和染色体微阵列分析,非整倍体和拷贝数变异以盲法检测分析。
  • 单核苷酸变异和插入缺失用Sanger测序确认,三核苷酸重复扩增变异用聚合酶链反应加片段长度分析验证。

主要发现

  • 全基因组测序遗传诊断28例(15.1%)。
  • 染色体微阵列分析诊断20例(10.8%),全基因组测序检出全部这20例的非整倍体和拷贝数变异。
  • 全基因组测序额外检出1例COL4A2外显子缺失和7例(3.8%)单核苷酸变异或插入缺失。
  • 检出3例偶然发现:ATXN3三核苷酸重复扩增、ATRX剪接位点变异和一例21三体中的ANXA11错义突变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Emerging studies suggest that whole genome sequencing provides additional diagnostic yield of genomic variants when compared with chromosomal microarray analysis in the etiologic diagnosis of infants and children with suspected genetic diseases. However, the application and evaluation of whole genome sequencing in prenatal diagnosis remain limited. OBJECTIVE: This study aimed to evaluate the accuracy, efficacy, and incremental yield of whole genome sequencing in comparison with chromosomal microarray analysis for routine prenatal diagnosis. STUDY DESIGN: In this prospective study, a total of 185 unselected singleton fetuses with ultrasound-detected structural anomalies were enrolled. In parallel, each sample was subjected to whole genome sequencing and chromosomal microarray analysis. Aneuploidies and copy number variations were detected and analyzed in a blinded fashion. Single nucleotide variations and insertions and deletions were confirmed by Sanger sequencing, and trinucleotide repeats expansion variants were verified using polymerase chain reaction plus fragment-length analysis. RESULTS: Overall, genetic diagnoses using whole genome sequencing were obtained for 28 (15.1%) cases. Whole genome sequencing not only detected all these aneuploidies and copy number variations in the 20 (10.8%) diagnosed cases identified by chromosomal microarray analysis, but also detected 1 case with an exonic deletion of COL4A2 and 7 (3.8%) cases with single nucleotide variations or insertions and deletions. In addition, 3 incidental findings were detected including an expansion of the trinucleotide repeat in ATXN3, a splice-sites variant in ATRX, and an ANXA11 missense mutation in a case of trisomy 21. CONCLUSION: Compared with chromosomal microarray analysis, whole genome sequencing increased the additional detection rate by 5.9% (11/185). Using whole genome sequencing, we detected not only aneuploidies and copy number variations, but also single nucleotide variations and insertions and deletions, trinucleotide repeat expansions, and exonic copy number variations with high accuracy in an acceptable turnaround time (3-4 weeks). Our results suggest that whole genome sequencing has the potential to be a new promising prenatal diagnostic test for fetal structural anomalies.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hu P, Zhang Q, Cheng Q, et al. Whole genome sequencing vs chromosomal microarray analysis in prenatal diagnosis. Am J Obstet Gynecol. 2023. PMID: 36907537. doi:10.1016/j.ajog.2023.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。